ILK and cancer: Among all the tumor associated canonical pathways enriched were GNRH signaling (p = 2.92E−04), cAMP-mediated signaling (p = 3.60E−04), Protein Kinase A signaling (p = 3.77E−04), CXCR4 signaling (p = 4.99E−03), molecular mechanisms of cancer (p = 8.58E−03), phospholipase C Signaling (p = 1.01E−02), RAR Activation (p = 3.16E−02), ILK Signaling (p = 4.21E−02)(Table S5, Figure 5).